This year we mark an International Clinical Trials Day like no other. The world is changed in the face of the COVID-19 pandemic, and we are all aware of the role and importance of clinical trials in researching treatments, cures and guarding our safety as we try to find a way to reduce the enormous toll of the coronavirus.
In 2020, we will be showcasing the essential work of our Members including the Clinical Trial Networks, Clinical Quality Registries and Coordinating Centres that support investigator-led clinical trials, comprising more than 10,000 doctors, nurses, allied health professionals and researchers.
ACTA is celebrating its Members, starting on International Clinical Trials Day. We are sharing their stories to highlight the work that goes on every day creating better health through best evidence.
-
ANZCA: ROCKet trial
In the field of anaesthesia, consumer involvement can be a challenge. Patients are referred by surgical teams, anaesthetists are in the middle where much of…
-
PREDICT: BELLPIC
The Paediatric Research in Emergency Departments International Collaborative (PREDICT) is an active Clinical Trial Network that aims to investigate best approaches to emergency treatment, and…
-
NTA: STOP-MSU
Neuroscience Trials Australia (NTA) has ensured that trials conducted by the group can embedded into routine practice—a conscious decision that CEO Dr Tina Soulis says…
-
ANZCA: BRACE trial
Photo by Hyttalo Souza on Unsplash Professor Andrew Davidson, Chair of Australian and New Zealand College of Anaesthetists (ANZCA) Clinical Trials Network, suggests that with proper funding and the…
Latest Resources
Latest News
-
Australian Clinical Trials shine at annual ACTA Awards
-
ACTA welcomes $1.89b investment in Australian health and medical research including support for a National One Stop Shop
-
Nominations now closed : 2024 ACTA Trial of the Year Awards
-
ACTA congratulates ALLG on 50 years of clinical trials impact
-
ACTA to offer free consumer ASM registrations
-
Accolades for Australian clinical trials at annual ACTA awards
-
Inaugural Emerging Leader Investigator Awards
-
Successful 2021 ACTA ASM
-
ANZGOG’S OUTBACK Trial Among the Most Important Cervical Cancer Research Advances in the Past Year
-
Member profile: ICU Hood
-
LIFEMend: a lifestyle approach to mental health
-
Breast Cancer Trials: An EXPERT trial to avoid unnecessary treatment
-
ANZGOG—improving life for women through cancer research
-
Monash SPHPM—renewed funding for ASPREE and recruitment for STaREE
-
TIA: Supporting the development of a COVID-19 Vaccine
-
AMaRC: FRAIL-M
-
Jean Hailes for Women’s Health: NECST
-
St Vincent’s Sydney: BELINDA Study
-
CTANZ: SUNRRISE & COVIDSurg
-
ANZFPS: ComeBACK
-
ANZUP: ENZAMET
-
ANZSA: SARC032
-
Australian Clinical Trials Alliance celebrating and honouring clinical trials on International Clinical Trials Day
-
ANZCA: ROCKet trial
-
ANZCA: BRACE trial
-
NTA: STOP-MSU
-
PREDICT: BELLPIC
Latest Events
-
Melanoma and Skin Cancer Trials Concept Development Workshop
-
2022 ACTA ASM including the Australian Registry ASM
-
ACTA CEO update – October 2022
-
ACTA CEO update – August 2022
-
ANZUP ASM 2022
-
Clinical Trials (CT) Socials
-
ACTA’s 2021 Annual General Meeting and Advisory Council Meeting
-
Australasian Gastro-Intestinal Trials Group 22nd Annual Scientific Meeting